William Blair Forecasts Weaker Earnings for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP - Free Report) - Stock analysts at William Blair reduced their Q1 2026 earnings per share estimates for Simulations Plus in a research report issued on Monday, January 27th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.16 for the quarter, down from their previous estimate of $0.17. William Blair has a "Outperform" rating on the stock. The consensus estimate for Simulations Plus' current full-year earnings is $1.09 per share. William Blair also issued estimates for Simulations Plus' Q2 2026 earnings at $0.31 EPS, Q4 2026 earnings at $0.41 EPS and FY2026 earnings at $1.32 EPS.

A number of other research firms have also recently commented on SLP. Stephens started coverage on shares of Simulations Plus in a research note on Friday, November 15th. They set an "overweight" rating and a $39.00 price target for the company. StockNews.com lowered shares of Simulations Plus from a "hold" rating to a "sell" rating in a research note on Monday, November 4th. KeyCorp boosted their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, BTIG Research lowered their price target on Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, October 24th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $49.40.

Simulations Plus Trading Down 0.6 %

NASDAQ:SLP traded down $0.19 during midday trading on Wednesday, hitting $33.80. 206,471 shares of the company traded hands, compared to its average volume of 336,293. The firm's fifty day moving average is $30.19 and its 200-day moving average is $32.70. The firm has a market capitalization of $679.04 million, a P/E ratio of 84.50 and a beta of 0.80. Simulations Plus has a 12-month low of $24.00 and a 12-month high of $51.22.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 19.40% of the stock is owned by insiders.

Institutional Trading of Simulations Plus

Several hedge funds have recently made changes to their positions in SLP. First Horizon Advisors Inc. lifted its stake in Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Simulations Plus by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company's stock worth $311,000 after buying an additional 456 shares during the last quarter. Pitcairn Co. boosted its holdings in shares of Simulations Plus by 9.1% in the 3rd quarter. Pitcairn Co. now owns 6,599 shares of the technology company's stock valued at $211,000 after buying an additional 549 shares in the last quarter. Franklin Resources Inc. grew its position in shares of Simulations Plus by 7.6% in the 3rd quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock valued at $342,000 after buying an additional 766 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in Simulations Plus by 1.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 54,813 shares of the technology company's stock worth $2,665,000 after acquiring an additional 784 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company's stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.